Comparative Evaluation of the Efficacy and Safety of High-Power Short-Duration Radiofrequency Ablation and Standard Low-Power Ablation in Catheter Treatment of Atrial Fibrillation

Recruiting N/A Interventional Study
Atrial Fibrillation (AF) Stroke Acute Cerebrovascular Accident Atrial Fibrillation Recurrent Death
Ready to participate?

Review the details below, then apply to join this clinical trial.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Atrial fibrillation (AF) is the most common cardiac arrhythmia and represents one of the leading causes of cardiovascular morbidity and mortality. According to current data, AF is associated with approximately 20% of all ischemic strokes, while the risk of stroke in patients with this arrhythmia is increased fivefold. Ischemic stroke in patients with AF is characterized by a more severe clinical c…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age over 18 years old; * Atrial fibrillation resistant to antiarrhythmic therapy; * Paroxysmal form of atrial fibrillation; * Persistent form of atrial fibrillation; * The patient's consent to participate in the study. Exclusion Criteria: Exclusion Criteria: * Age under 18 …
Contacts

Andrey Filatov

+7(495) 414-77-02

agfilatov@bakulev.ru

CONTACT